(SYRE)

Markets

Spyre Therapeutics Inc (SYRE) volume exceeds 0.53 million: A new investment opportunity for investors

Steve Mayer

On Tuesday, Spyre Therapeutics Inc (NASDAQ: SYRE) opened higher 5.28% from the last session, before settling in for the closing ...

Markets

Spyre Therapeutics Inc (SYRE) recently have taken one step ahead with the beta value of 2.98

Steve Mayer

Witnessing the stock’s movement on the chart, on Wednesday, Spyre Therapeutics Inc (NASDAQ: SYRE) set off with pace as it ...

News Daemon
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.